AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,393,956 | +3.9% | 1,430,424 | +7.3% | 0.11% | +9.1% |
| Q2 2023 | $16,748,057 | +10.5% | 1,333,444 | -2.5% | 0.10% | +3.1% |
| Q1 2023 | $15,159,642 | -0.1% | 1,366,965 | +9.9% | 0.10% | -4.0% |
| Q4 2022 | $15,181,438 | +20.1% | 1,243,361 | +2.7% | 0.10% | +13.6% |
| Q3 2022 | $12,643,000 | +7.1% | 1,211,005 | +10.2% | 0.09% | +14.3% |
| Q2 2022 | $11,801,000 | +23.9% | 1,098,797 | +9.2% | 0.08% | +48.1% |
| Q1 2022 | $9,528,000 | -15.0% | 1,006,132 | +3.7% | 0.05% | -11.9% |
| Q4 2021 | $11,206,000 | +60.3% | 970,181 | +32.6% | 0.06% | +59.5% |
| Q3 2021 | $6,990,000 | +20.1% | 731,906 | +21.2% | 0.04% | +19.4% |
| Q2 2021 | $5,821,000 | +99.3% | 603,855 | +104.3% | 0.03% | +93.8% |
| Q1 2021 | $2,920,000 | -75.9% | 295,588 | -43.6% | 0.02% | -77.8% |
| Q4 2020 | $12,104,000 | -16.7% | 524,189 | -49.0% | 0.07% | -20.9% |
| Q3 2020 | $14,524,000 | -36.2% | 1,028,584 | -31.9% | 0.09% | -37.2% |
| Q2 2020 | $22,764,000 | +59.5% | 1,509,552 | -2.3% | 0.14% | +43.6% |
| Q1 2020 | $14,274,000 | +205.8% | 1,544,819 | +222.4% | 0.10% | +381.0% |
| Q4 2019 | $4,667,000 | +6206.8% | 479,144 | +6147.0% | 0.02% | – |
| Q4 2015 | $74,000 | -55.2% | 7,670 | -35.2% | 0.00% | -100.0% |
| Q3 2015 | $165,000 | -65.1% | 11,830 | -64.6% | 0.00% | -50.0% |
| Q2 2015 | $473,000 | -34.4% | 33,422 | -49.6% | 0.00% | -50.0% |
| Q1 2015 | $721,000 | – | 66,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |